Elevance Health Inc. (ELV) Tops Q4 EPS by 23c; offers outlook

Elevance Health Inc. (NYSE: ELV) reported Q4 EPS of $3.33, $0.23 better than the analyst estimate of $3.10. Revenue for the quarter came in at $49.3 billion versus the consensus estimate of $49.82 billion.

GUIDANCE:

Elevance Health Inc. sees FY2026 EPS of $25.50, versus the consensus of $26.80.

For earnings history and earnings-related data on Elevance Health Inc. (ELV) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Full Circle Lithium closes $5.14M private placement
• Phillips 66, Marathon Merger Talks Collapsed - Semafor